Meanwhile, the T2-low asthma group showed median serum levels of YKL-40 and DPP4 at 30.9 ng/mL (Q1–Q3: 17.0–44.4) and 1105.5 ng/mL (931.4–1444.8), correspondingly. This evidence concerns the gene CHI3L1 and asthma.